In a well-established breast cancer stem cells model, investigators identified that pharmacological inhibition of the mechanistic target of rapamycin (mTOR), suppressed Sal-induced ferroptosis.
[Cell Death & Disease]
mTOR Inhibition Suppresses Salinomycin-Induced Ferroptosis in Breast Cancer Stem Cells by Ironing Out Mitochondrial Dysfunctions
